Meeting the unmet need in Chronic Lymphocytic Leukaemia during Covid-19 era (the triumph of ibrutinib) - 23 June 2020

Part 1 - Chairpersons's Remarks - Dr M B Agarwal, Mumbai
Part 2 - Using ibrutinib in a relapsed /refractary CLL - A case presentation - Dr Shilpa Bhartia
Part 3 - Using ibrutinib in a high-risk CLL -A case presentation - Dr Ganesh Jashetwar, Hyderabad
Part 4 - Using ibrutinib in an aged / unfit CLL - A case presentation - Dr Subhaprakash Sanyal
Part 5- Panel Discussion- Oral therapy for CLL in India during Covid-19 era - Dr Anusree Prabhakaran
Part 6 - Question & Answer Session Moderated By - Dr Sandip Shah, Ahmedabad